Synopsys (SNPS) FY2015 results: revenue $2.2 billion, up 9.0% on the year
Synopsys Inc. (SNPS) reported revenue of $2.2 billion for fiscal 2015, the year ended 31 October 2015, up 9.0% on the year before. Net income was $226 million, down 12.8%, and diluted earnings per share $1.43. The figures are the company's own, from the 10-K it filed with the SEC on 14 December 2015.
Revenue
$2.2 billion
+9.0% on the year
FY2008FY2015
Operating margin
11.9%
12.1% a year earlier
FY2008FY2015
Net income
$226 million
-12.8% on the year
FY2008FY2015
Diluted EPS
$1.43
-12.8% on the year
FY2008FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
2,242
2,057
1,962
+9.0%
Cost of revenue
519
457
454
+13.6%
Gross profit
1,723
1,601
1,509
+7.7%
Gross margin
76.9%
77.8%
76.9%
Research and development
776
719
669
+8.0%
Operating income
266
249
246
+7.1%
Operating margin
11.9%
12.1%
12.6%
Interest expense
2.8
1.9
1.7
+48.5%
Pre-tax income
282
272
276
+3.5%
Income tax
55.7
13.0
27.9
+327.7%
Effective tax rate
19.8%
4.8%
10.1%
Net income
226
259
248
-12.8%
Net margin
10.1%
12.6%
12.6%
Diluted EPS
$1.43
$1.64
$1.58
-12.8%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
495
551
497
-10.1%
Capital expenditure
87.0
103
65.5
-15.8%
Free cash flow
408
448
431
-8.8%
Free cash flow margin
18.2%
21.8%
22.0%
Cash from investing
n/a
-497
-66.1
Cash from financing
n/a
-73.7
-98.0
Depreciation and amortisation
212
193
187
+9.9%
Share-based compensation
86.4
79.4
67.5
+8.8%
Buybacks
260
120
145
+117.1%
Diluted shares, weighted
158m
158m
157m
+0.2%
Shares outstanding at period end
155m
156m
154m
-0.5%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
3,134
3,056
2,788
+2.5%
Debt
205
75.0
105
+173.3%
Other liabilities
1,707
1,644
1,466
+3.8%
Total liabilities and equity
5,046
4,775
4,359
+5.7%
Fixed assets
263
249
198
+5.6%
Goodwill
2,471
2,256
1,976
+9.6%
Intangible assets
364
365
335
-0.4%
Investments
129
0.0
n/a
Cash and equivalents
836
986
1,022
-15.2%
Receivables
386
327
256
+18.0%
Other assets
597
593
571
+0.7%
Total assets
5,046
4,775
4,359
+5.7%
10-K for the year ended 31 October 2015, filed 14 December 2015: the filing.